Navigation Links
Glenmark Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea
Date:12/6/2007

Pharmaceuticals, Inc. focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace in collaboration with local partners. Napo was founded in November 2001, and is based in California, USA with a subsidiary in Mumbai, India. Napo's late-stage proprietary gastro-intestinal compound, crofelemer, is in various stages of clinical development for four distinct product indications, including a late-stage Phase 3 program:
-- CRO-HIV for AIDS diarrhea, Phase 3

-- CRO-IBS for diarrhea irritable bowel syndrome ("D-IBS"), Phase 2

-- CRO-ID for acute infectious diarrhea (including cholera), Phase 2

-- CRO-PED for pediatric diarrhea, Phase 1

The FDA has granted fast-track status to CRO-IBS and CRO-HIV.

Crofelemer, a proprietary patented agent, is extracted from Croton lechleri, a medicinal plant which can be sustainably harvested from several countries in South America. Napo also plans to develop an early clinical stage product, NP-500, for the treatment of insulin resistant diseases of Type II diabetes and metabolic syndrome (Syndrome X; pre-diabetic syndrome). Napo also has a plant library of approximately 2,300 medicinal plants from tropical regions, and Napo has entered two screening relationships associated with this collection. Currently, products are based on the chemical and biological diversity derived from plants with medicinal properties, but future products may be in-licensed from other sources.

Napo has partnerships with Trine Pharmaceuticals, Inc. of the United States; Glenmark Pharmaceuticals Limited of India; and AsiaPharm Group Ltd. of China. For more information please visit http://www.napopharma.com.

About Glenmark

Glenmark Pharmaceuticals Limited is a research-led, global, fully integrated pharmaceutical company headquartered in Mumbai, India. The Company is a leader in India in the discovery of new
'/>"/>

SOURCE Napo Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly and Glenmark Pharmaceuticals Announce License Agreement
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... NxStage® Kidney Care, Inc ., a subsidiary of NxStage® Medical, ... the grand opening ceremony of its Oak Brook, ... Street on November 20, 2014 from 3pm – 7pm. The Oak ... are committed to providing patients with enhanced access to the ... more flexible dialysis treatment options.   The facility ...
(Date:10/30/2014)... Calif. , Oct. 30, 2014  Electronic ... dramatically as a result of government initiatives and ... - healthcare providers have invested over the past ... heart of health IT, and U.S. clinicians use ... Logo - http://photos.prnewswire.com/prnh/20141029/155278LOGO ...
(Date:10/30/2014)...  Nektar Therapeutics (Nasdaq: NKTR ) will ... September 30, 2014 on Thursday, November 6, 2014, after ... , president and chief executive officer, will host a ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... Webcast of the conference call can be accessed through ...
Breaking Medicine Technology:Grand Opening of NxStage Kidney Care Oak Brook IL Center 2Grand Opening of NxStage Kidney Care Oak Brook IL Center 3Electronic Health Record Usability: CIOs Weigh In 2Electronic Health Record Usability: CIOs Weigh In 3Electronic Health Record Usability: CIOs Weigh In 4Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2
... Ontario, April 18, 2011 GlaxoSmithKline (GSK) and Valeant ... 15 April 2011 to the U.S. Food and Drug ... 2010 for the New Drug Application (NDA) for ezogabine*. ... studied for the adjunctive treatment of adults with partial-onset ...
... TARRYTOWN, N.Y., April 18, 2011 Regeneron Pharmaceuticals, Inc. ... U.S. Food and Drug Administration (FDA) has accepted for ... Trap-Eye for the treatment of the neovascular form of ... the Company,s request for priority review of its BLA. ...
Cached Medicine Technology:Regulatory Update - GSK and Valeant Respond to FDA on ezogabine 2Regulatory Update - GSK and Valeant Respond to FDA on ezogabine 3FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 2FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 3
(Date:10/31/2014)... A new report by Milken Institute School of ... Washington University examines the challenge of maintaining enriched ... in Covered California and who are also eligible ... Program (CPSP). The CPSP, whose roots are in ... developed for low-income pregnant women, makes enriched maternity ...
(Date:10/30/2014)... Albert Einstein College of Medicine of ... will present their latest aging research at the ... Meeting. Topics include the identification of a genotype ... impairment and the cellular biology of aging. GSA ... Washington, D.C., "Einstein-Montefiore has distinguished itself in a ...
(Date:10/30/2014)... 2014—Analysis of data from an institutional patient registry ... local control, 79 percent of tumors, for medically ... SBRT from 2003 to 2012, according to research ... in Thoracic Oncology. The Symposium is sponsored by ... American Society for Radiation Oncology (ASTRO), the International ...
(Date:10/30/2014)... research group at the DFG Research Center for Regenerative ... Dresden (CRTD) demonstrated for the first time the in ... three dimensions from mouse embryonic stem cells. Correct spatial ... the dorsal/ventral axis was observed., This study has been ... Cell Reports " on 30.10.2014 ., For many years ...
(Date:10/30/2014)... Nutrition Leaders, a popular online retailer ... and more, is currently hosting a sweepstakes on its ... is open to U.S. residents age 18 and over, ... One lucky winner will then be selected at random ... card to NutritionLeaders.com. , Nutrition Leaders’ managing director Kimba ...
Breaking Medicine News(10 mins):Health News:Report examines health care challenges for pregnant women enrolled in covered California 2Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 2Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 3Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 4Health News:Sustained local control for medically inoperable, early stage lung cancer patients 2Health News:Sustained local control for medically inoperable, early stage lung cancer patients 3Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:Nutrition Leaders Announces Gift Card Sweepstakes 2
... stress hormones may be disregulated in people with chronic ... that helps the body deal with physical and psychological ... stress hormone cortisol by the adrenal glands. ... tiredness. It's cause is not well understood, but some ...
... Hopkins University observed that a chest compression belt outperforms ... //When someone has a cardiac arrest, it's vital to ... soon as possible. Usually this is done by applying ... rhythm, but these are usually not available in those ...
... surgery for emphysema does not help the sickest patients, ... of the lungs - the alveoli - are progressively ... they cannot do everyday activities like climbing stairs or ... suggest that lung reduction surgery was beneficial for people ...
... high levels of C-reactive protein and low levels of albumin ... the 25% of patients who die while on kidney dialysis,// ... such patients run between five and one hundred times the ... population. ,Doctors at Johns Hopkins University have surveyed ...
... the dangers of getting a lung infection or irritation from a ... hot tub, or jacuzzi, at home or in a health club. ... clean// and well-maintained in order to avoid developing a problem with ... have investigated two patients presenting with 'hot tub lung' - a ...
... in the US have more hospital admissions for respiratory ... pollution and public health. Now doctors at the University ... on Medicare costs in a large group of the ... pollution measures in 185 metropolitan areas. They found that ...
Cached Medicine News:
An adhesive-backed hanger, designed for use where space is limited (fume hoods, sterile hoods, etc.). Sticks to any smooth, dry surface without damage. Resistant to chemicals and UV light....
Four Tiered Pipette Rack. Made for disposable plastic pipettes. Designed for removal of pipettes from the right side. Three tiered and left side removal racks are also available...
... Pipette Tracker is an automated solution ... calibration and performance testing for all pipettes ... directly from any balance Supports ... ISO 8655, DIN 12650, ISO 9000, NCCLS ...
... to configure for gravimetric calibration and is ... method or enter your own parameters (number ... automatically manages the calibration protocol with direct ... to the software, which establishes the calibration ...
Medicine Products: